Infectious Disease Diagnostics Market Size
The global infectious disease diagnostics market was valued at USD 33.86 Billion in 2021 and is expected to reach around USD 44.85 Billion by 2030, at a CAGR of about 3.2% between 2022 and 2030.
Infectious Disease Diagnostics Market Overview
Diagnostics are extremely important in defining the course of any medical treatment. Diagnostics for infectious diseases assist in the diagnosis of diseases caused by pathogenic infection. The world of diagnostics is continuously changing, and the global market for infectious diseases diagnostics has been steadily increasing in recent years. Infectious diseases are caused by bacteria, viruses, and other organisms, and they have a significant impact on countries' healthcare systems. The process of identifying the causative organism for the primary diagnosis of disorders is known as infectious disease testing. Blood, urine, and other biological fluids are used to screen for infectious diseases. Because diagnosis is the first step in disease management, infectious disease testing is critical in primary care settings.
COVID-19 Impact Analysis on Infectious Disease Diagnostics Market
The new coronavirus causes COVID-19, an infectious disease. COVID-19, which was mostly unknown before the outbreak in Wuhan, China, in December 2019, went from a regional issue to a global pandemic in a matter of weeks. COVID-19 was declared a pandemic by the World Health Organization (WHO) on March 11, 2020.
Government organizations around the world are assisting laboratories in expediting COVID-19 testing methods, since testing remains a critical step in preventing the disease's rapid spread. The COVID-19 pandemic had a negative influence on most companies' overall sales, but it had a favorable impact on the infectious illness diagnostics industry since infectious disease diagnostic procedures were used for COVID-19 testing. As a result, regulatory authorities used a variety of techniques to expedite the certification of COVID-19 diagnostic products. Furthermore, significant corporations have made strategic investments to adopt COVID-19 quick tests and reduce the impact of COVID-19 on their operating capabilities, since diagnostic testing continues to be the backbone of the COVID-19 response, enabling containment and mitigation activities. Furthermore, the severity of the crisis, as well as the growing capacity issues associated with PCR-based testing, has pushed the development of diagnostic solutions to fulfil the demand for mass testing. COVID-19 testing and tracking procedures were built up by major players in the market.
The COVID-19 pandemic, on the other hand, has continued to exhibit a dramatic reduction around the world this year, with contaminations slowing down everywhere, resulting in a decrease in the infectious disease diagnostics market's growth rate. The WHO has been working with nations and areas in the Western Pacific Region on public health measures to slow or stop the spread of COVID-19 since the outbreak began. Vaccines, in combination with other measures, are an important strategy for protecting people against COVID-19 and reducing widespread societal disruption.
Infectious Disease Diagnostics Market Dynamics
Increased prevalence of infectious diseases such as influenza, COVID-19, hepatitis and human immunodeficiency virus (HIV); increased demand for point-of-care diagnostic tests; increased funding from private and government organizations for diagnostic service centers; and advancements in infectious disease diagnostic technologies are driving the global infectious disease diagnostic market.
According to the Centers for Disease Control and Prevention (CDC), around 1.7 million illnesses and 99,000 related deaths occur each year in American hospitals, according to the CDC. Furthermore, the infection disease diagnostic market is expected to develop due to an increase in demand for point-of-care testing.
Infectious Disease Diagnostics Market Drivers
- Shift in focus from centralized laboratories to decentralized POC testing
- Rising technological advancements in infectious disease diagnostics
- Increase in prevalence of infection diseases
Infectious Disease Diagnostics Market Restraints
- Lack of skilled professional and trained personnel
- High cost of diagnostic instruments
Infectious Disease Diagnostics Market Opportunities
- Development of advanced diagnostic devices by key players
Infectious Disease Diagnostics Market Segmental Analysis
Infectious Disease Diagnostics Market, By Product
The assays & reagents category dominated the market in 2020, owing to increased R&D activities in the pharmaceutical & biotechnology industry, higher demand for reagents, and increased adoption of point-of-care testing, and this trend is expected to continue during the forecast period.
The instruments segment, on the other hand, is expected to grow significantly during the forecast period due to an increase in the number of research laboratories and increased funding by government and private organizations for the development of diagnostic instruments in the pharmaceutical and biotechnology industries.
Infectious Disease Diagnostics Market, By Technology
The others segment dominated the market in 2020, and this trend is expected to continue during the forecast period, thanks to a large number of key players offering advanced diagnostic medical devices, increased demand for DNA analysis, development of novel & innovative PCR tools, and advancement in R&D activities for infectious disease diagnosis.
The immunodiagnostic segment, on the other hand, is expected to rise significantly over the projection period due to an increase in the number of genomic projects, increasing awareness about DNA sequencing, and improvements in R&D for DNA analysis activities.
Infectious Disease Diagnostics Market Regional Analysis
North America dominates the market, because of the rise in infectious disease prevalence, the presence of key players, the development of the healthcare sector, the presence of national clinical laboratories, and advancements in diagnostic instrument technology in the region. However, due to a growth in the prevalence of infectious diseases, a rise in demand for early diagnosis, the development of healthcare infrastructure, and technical advancements in diagnostic testing, Asia-Pacific is predicted to have the highest CAGR percent from 2021 to 2030.
Infectious Disease Diagnostics Key Market Players
- Abbott Laboratories
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche Ltd.
- bioMérieux SA
- Siemens Healthineers AG
- Danaher Corporation
- Becton, Dickinson and Company
- PerkinElmer, Inc.
- Hologic, Inc.
- QIAGEN N.V.
- Grifols S.A.
- DiaSorin S.p.A
- Bio-Rad Laboratories, Inc.
- Sysmex Corporation
- Ortho Clinical Diagnostics Holdings plc
- Quidel Corporation
- Meridian Bioscience
- Genetic Signatures Ltd.
- OraSure Technologies
- Trinity Biotech Plc.
- Chembio Diagnostic Systems
- Seegene, Inc.
- Epitope Diagnostics
- Trivitron Healthcare
- Meril Life Sciences Pvt. Ltd.
- InBios International
- Vela Diagnostics
- Uniogen Oy
Infectious Disease Diagnostics Market Scope
|Market Size in 2021||USD 33.86 billion|
|Market Size in 2030||USD 44.85 billion|
|CAGR (%)||3.2% from 2022 to 2030|
|Historic Period||2018 – 2020|
|Forecast Period||2022 – 2030|
|Segments Covered||Product, Testing Type, Disease Type, Technology, End User|
|Regional Scope||North America, Europe, Asia Pacific, Latin America, Middle East & Africa|
|Key Companies Profiled||Abbott Laboratories, BioMerieus SA, Danaher Corporation, Becton Dickinson and Company, Luminex Corporation, Hologic Inc., Bio-Rad Laboratories, F Hoffman-La Roche, Qiagen Inc., Thermo Fisher Scientific Inc, Others|
Infectious Disease Diagnostics Market Segmentation
Global Infectious Disease Diagnostics Market, By Product
- Reagents, Kits, and Consumables
- Software & Services
Global Infectious Disease Diagnostics Market, By Testing Type
- POC Testing
- Laboratory Testing
Global Infectious Disease Diagnostics Market, By Disease Type
- Hospital-acquired Infections
- Chlamydia Trachomatis
- Neisseria Gonorrhea
- Mosquito-borne Diseases
Global Infectious Disease Diagnostics Market, By Technology
- Polymerase Chain Reaction (PCR)
- DNA Sequencing & NGS
- In Situ Hybridization
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Chips and Microarrays
- Transcription Mediated Amplification
- Mass Spectrometry
Global Infectious Disease Diagnostics Market, By End User
- Hospitals & Clinics
- Diagnostic Laboratories
- Academic Research Institutes
Global Infectious Disease Diagnostics Market, By Region
- North America
- Rest of North America
- Rest of Europe
- Asia Pacific
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa